Clinical trial
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for…
NCT00416403 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00416403 |
|---|---|
| Title | Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer |
| Official title | Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | fluvastatin sodium, Breast Cancer Surgery Only - Arm III |
| Enrollment | 35 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Jun 1, 2011 |
| First posted | Dec 28, 2006 |
| Last update posted | Dec 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: